BR112018005457A2 - peptídeo cíclico, composição cosmética ou dermatológica, e, loção para os olhos. - Google Patents
peptídeo cíclico, composição cosmética ou dermatológica, e, loção para os olhos.Info
- Publication number
- BR112018005457A2 BR112018005457A2 BR112018005457-7A BR112018005457A BR112018005457A2 BR 112018005457 A2 BR112018005457 A2 BR 112018005457A2 BR 112018005457 A BR112018005457 A BR 112018005457A BR 112018005457 A2 BR112018005457 A2 BR 112018005457A2
- Authority
- BR
- Brazil
- Prior art keywords
- cyclic peptide
- cosmetic
- dermatological composition
- eye lotion
- oocyte
- Prior art date
Links
- 108010069514 Cyclic Peptides Proteins 0.000 title abstract 3
- 102000001189 Cyclic Peptides Human genes 0.000 title abstract 3
- 239000002537 cosmetic Substances 0.000 title 1
- 239000006210 lotion Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 210000000287 oocyte Anatomy 0.000 abstract 2
- 102000001133 Fertilins Human genes 0.000 abstract 1
- 108010069446 Fertilins Proteins 0.000 abstract 1
- 230000006567 cellular energy metabolism Effects 0.000 abstract 1
- 210000002308 embryonic cell Anatomy 0.000 abstract 1
- 230000037149 energy metabolism Effects 0.000 abstract 1
- 230000004720 fertilization Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 102000006495 integrins Human genes 0.000 abstract 1
- 108010044426 integrins Proteins 0.000 abstract 1
- 230000035800 maturation Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B63—SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
- B63B—SHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING
- B63B21/00—Tying-up; Shifting, towing, or pushing equipment; Anchoring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B63—SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
- B63B—SHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING
- B63B21/00—Tying-up; Shifting, towing, or pushing equipment; Anchoring
- B63B2021/003—Mooring or anchoring equipment, not otherwise provided for
- B63B2021/004—Quick release elements in mooring connections
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Birds (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Ophthalmology & Optometry (AREA)
- Combustion & Propulsion (AREA)
- Mechanical Engineering (AREA)
- Ocean & Marine Engineering (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
a invenção se refere ao uso de um peptídeo cíclico compreendendo o tripeptídeo reproduzindo um local de ligação de beta fertilina ao oócito integrina, para melhorar metabolismo de energia celular. mais particularmente, a invenção diz respeito ao uso de um peptídeo cíclico compreendendo o tripeptídeo feec para estimular o metabolismo de energia dos gametas ou células embrionárias no contexto de protocolos de procriação medicamente assistida (map), em particular promovendo a maturação in vitro do oócito, a taxa de fertilização e a taxa de nascimento.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1558899A FR3041260B1 (fr) | 2015-09-21 | 2015-09-21 | Utilisation d'un tripeptide cyclique pour stimuler l'activite mitochondriale de cellules |
| FR1558899 | 2015-09-21 | ||
| PCT/EP2016/072476 WO2017050854A1 (fr) | 2015-09-21 | 2016-09-21 | Utilisation d'un tripeptide cyclique pour ameliorer le metabolisme energetique cellulaire |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112018005457A2 true BR112018005457A2 (pt) | 2018-10-09 |
| BR112018005457A8 BR112018005457A8 (pt) | 2022-11-08 |
Family
ID=56263743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018005457A BR112018005457A8 (pt) | 2015-09-21 | 2016-09-21 | Peptídeo cíclico, composição cosmética ou dermatológica, e, loção para os olhos. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US11278589B2 (pt) |
| EP (1) | EP3352775B1 (pt) |
| JP (1) | JP6918804B2 (pt) |
| KR (1) | KR20180133373A (pt) |
| CN (1) | CN109069579B (pt) |
| AU (1) | AU2016325378B2 (pt) |
| BR (1) | BR112018005457A8 (pt) |
| CA (1) | CA2998747A1 (pt) |
| ES (1) | ES2969739T3 (pt) |
| FR (1) | FR3041260B1 (pt) |
| HK (1) | HK1258383A1 (pt) |
| IL (1) | IL258178B2 (pt) |
| MA (1) | MA42928B1 (pt) |
| RU (1) | RU2737116C2 (pt) |
| WO (1) | WO2017050854A1 (pt) |
| ZA (1) | ZA201802132B (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019097290A1 (en) * | 2017-11-15 | 2019-05-23 | Aratinga.Bio | Enhancement of biologics production in cell culture systems by fertilin-derived peptides |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2862225B1 (fr) * | 2003-11-19 | 2006-06-02 | Univ Paris 13 | Peptide augmentant la capacite fusiogene de l'ovocyte |
| ITMI20040255A1 (it) * | 2004-02-17 | 2004-05-17 | Univ Degli Studi Milano | Sostanze ad attivita' antiangiogenica |
| RU2005128993A (ru) * | 2005-09-08 | 2007-03-20 | Общество С Ограниченной Ответственностью Исследовательский Центр "Комкон" (Ru) | Средство для коррекции стресс-индуцируемых нейромедиаторных, нейроэндокринных и метаболических нарушений, а также способ профилактики и лечения сопутствующих им паталогических состояний |
-
2015
- 2015-09-21 FR FR1558899A patent/FR3041260B1/fr active Active
-
2016
- 2016-09-21 RU RU2018114660A patent/RU2737116C2/ru active
- 2016-09-21 ES ES16775555T patent/ES2969739T3/es active Active
- 2016-09-21 CA CA2998747A patent/CA2998747A1/fr active Pending
- 2016-09-21 BR BR112018005457A patent/BR112018005457A8/pt active Search and Examination
- 2016-09-21 IL IL258178A patent/IL258178B2/en unknown
- 2016-09-21 WO PCT/EP2016/072476 patent/WO2017050854A1/fr active Application Filing
- 2016-09-21 US US15/761,825 patent/US11278589B2/en active Active
- 2016-09-21 KR KR1020187011126A patent/KR20180133373A/ko not_active Application Discontinuation
- 2016-09-21 AU AU2016325378A patent/AU2016325378B2/en active Active
- 2016-09-21 EP EP16775555.2A patent/EP3352775B1/fr active Active
- 2016-09-21 JP JP2018534019A patent/JP6918804B2/ja active Active
- 2016-09-21 CN CN201680067857.2A patent/CN109069579B/zh active Active
- 2016-09-21 MA MA42928A patent/MA42928B1/fr unknown
-
2018
- 2018-04-03 ZA ZA2018/02132A patent/ZA201802132B/en unknown
-
2019
- 2019-01-17 HK HK19100781.2A patent/HK1258383A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017050854A1 (fr) | 2017-03-30 |
| EP3352775C0 (fr) | 2023-11-01 |
| JP2018536013A (ja) | 2018-12-06 |
| KR20180133373A (ko) | 2018-12-14 |
| US11278589B2 (en) | 2022-03-22 |
| FR3041260A1 (fr) | 2017-03-24 |
| US20180264075A1 (en) | 2018-09-20 |
| CN109069579A (zh) | 2018-12-21 |
| CA2998747A1 (fr) | 2017-03-30 |
| ES2969739T3 (es) | 2024-05-22 |
| ZA201802132B (en) | 2019-09-25 |
| RU2018114660A3 (pt) | 2020-03-02 |
| CN109069579B (zh) | 2022-04-29 |
| FR3041260B1 (fr) | 2020-10-02 |
| EP3352775B1 (fr) | 2023-11-01 |
| IL258178B1 (en) | 2023-11-01 |
| IL258178B2 (en) | 2024-03-01 |
| RU2018114660A (ru) | 2019-10-23 |
| HK1258383A1 (zh) | 2019-11-08 |
| IL258178A (en) | 2018-05-31 |
| EP3352775A1 (fr) | 2018-08-01 |
| RU2737116C2 (ru) | 2020-11-24 |
| AU2016325378A1 (en) | 2018-04-19 |
| AU2016325378B2 (en) | 2020-08-20 |
| MA42928A (fr) | 2018-08-01 |
| JP6918804B2 (ja) | 2021-08-11 |
| MA42928B1 (fr) | 2024-01-31 |
| BR112018005457A8 (pt) | 2022-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP20075163A (es) | Moléculas de unión contra bcma y usos de las mismas | |
| BR112018067696A2 (pt) | membros de ligação à pd-l1 | |
| BR112018005110A2 (pt) | Composição emoliente e sua utilização cosmética, composição cosmética, dermatológica ou farmacêutica e sua utilização cosmética e processo de tratamento cosmético da pele | |
| BR112014006158A2 (pt) | molécula de ligação, molécula de ácido nucléico, vetor, célula hospedeira, processo para preparar uma molécula de ligação, métodos para acentuar uma resposta imune em um indivíduo humano, para tratar câncer em um indivíduo humano em necessidade do mesmo, para reduzir o tamanho de um tumor ou inibir o crescimento de células cancerosas em um indivíduo ou reduzir ou inibir o desenvolvimento do câncer metastático em um indivíduo sofrendo de câncer, uso de uma molécula de ligação, e, composição farmacêutica | |
| BR112015005301A2 (pt) | composições cosméticas biofotônicas | |
| AR093377A1 (es) | Anticuerpos anti-notch y conjugados de anticuerpo-farmaco | |
| BR112016027585A2 (pt) | construções de anticorpo multiespecíficas | |
| BR112016007622A2 (pt) | composto, composição farmacêutica, conjugado de ligante-droga, e, método para tratar câncer | |
| AR080873A1 (es) | Anticuerpos contra factor de crecimiento epidermico (anti-erbb3 o anti-her3) | |
| CL2012002416A1 (es) | Proteina de union capaz de unirse a dll4; construccion de anticuerpo que comprende dicha proteina; conjugado de anticuerpo; acido nucleico, vector y celula huesped que comprenden el anticuerpo; composicion para la liberacion de una proteina de union; metodo para reducir la actividad del dll4 humano. | |
| BR112014026990A2 (pt) | anticorpo , ácido nucleico , vetores , célula hospedeira , composição farmacêutica , uso de um anticorpo e método para o tratamento de um paciente com necessidade de terapia. | |
| BR112012013717A2 (pt) | "anticorpo de ligação ao csf-1r humano, composição farmacêutica, ácido nuleico, vetor de expressão, célula hospedeira procariótica ou eucariótica , método para a produção de um anticorpo recombinate, uso do anticorpo emétodo para o tratamento de um paciente qur sofre de câncer, de metástase e de doenças inflamatórias" | |
| BR112014018728A8 (pt) | Compostos de purinonas como inibidores de quinase | |
| BR112014005355A2 (pt) | células t de memória central anti-terceiro, métodos de produção e uso das mesmas em transplante e tratamento de doença | |
| WO2012021249A3 (en) | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases | |
| EP2575856A4 (en) | INNOVATIVE DISCOVERY OF THERAPEUTIC COMPOSITIONS, DIAGNOSTICS AND ANTIBODIES RELATED TO PROTEIN FRAGMENTS OF GLUTAMINYL-ARNT SYNTHETASES | |
| BR112017023391A2 (pt) | ?composição, método para preparar uma composição e métodos para melhorar a hidratação da pele? | |
| BR112015005653A8 (pt) | estimulação de desenvolvimento de folículo ovariano e maturação de oócitos | |
| CL2015002692A1 (es) | Novedosos compuestos de bencenosulfonamida, método para sintetizarlos y uso de los compuestos en medicina y en cosméticos. | |
| DOP2015000211A (es) | Anticuerpos anti-cd52 | |
| BR112017001696A2 (pt) | composições de célula-tronco e métodos de produção de células-tronco para aplicações terapêuticas | |
| WO2015001013A3 (en) | Human anti-ifn-alpha antibodies | |
| BR112018006152A2 (pt) | uso de células matriciais, processo ?in vitro? para preparar um microfolículo de cabelo, microfolículo de cabelo, uso de um microfolículo de cabelo e processo de triagem de produtos | |
| BR112018005457A2 (pt) | peptídeo cíclico, composição cosmética ou dermatológica, e, loção para os olhos. | |
| TR201905218T4 (tr) | Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (FR) ; INSERM PARIS (FR) ; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) ; UNIVERSITE DE PARIS (FR) |
|
| B25D | Requested change of name of applicant approved |
Owner name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (FR) ; INSERM PARIS (FR) ; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) ; UNIVERSITE PARIS CITE (FR) |